Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents

Published:2009-09-27 Issue:4 Volume:65 Page:625-639
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

O’Reilly Terence,McSheehy Paul M. J.,Kawai R.,Kretz O.,McMahon L.,Brueggen J.,Bruelisauer A.,Gschwind H.-P.,Allegrini P. R.,Lane H. A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-1068-8.pdf

Reference34 articles.

1. Boulay A, Lane HA (2007) The mammalian target of rapamycin kinase and tumor growth inhibition. Recent Results Cancer Res 172:99–124

2. Albanell J, Dalmases A, Rovira A, Rojo F (2007) mTOR signalling in human cancer. Clin Transl Oncol 9:484–493

3. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22

4. Abraham RT, Eng CH (2008) Mammalian target of rapamycin as a therapeutic target in oncology. Expert Opin Ther Targets 12:209–222

5. Jiang BH, Lui LZ (2008) Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updat 11:63–76

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing‐time, feeding, and sex‐dependent variations of everolimus pharmacokinetics in mice;Fundamental & Clinical Pharmacology;2024-03-18

2. Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma;Molecular Therapy - Methods & Clinical Development;2023-12

3. Lipid metabolism in malignant tumor brain metastasis: reprogramming and therapeutic potential;Expert Opinion on Therapeutic Targets;2023-09-02

4. Novel Adjuvant Targeted Approach for PTEN-Mutated Choroid Plexus Carcinoma in Adults: Case Report and Literature Review;JCO Precision Oncology;2023-08

5. Inhibitors of the Mechanistic Target of Rapamycin Can Ameliorate Bortezomib-Induced Peripheral Neuropathy;Biological and Pharmaceutical Bulletin;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3